Upregulation of skeletal muscle inflammatory genes links inflammation with insulin resistance in women with the metabolic syndrome

Experimental Physiology

Volumn 98, Issue 10, 2013, Pages 1485-1494

  Poelkens, Fleur ^a   Lammers, Gerwen ^a   Pardoel, Elisabeth M ^a   Tack, Cees J ^a   Hopman, Maria T E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CD97 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTONE DEACETYLASE 9; HYDROLASE; INTERLEUKIN 6 RECEPTOR; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FAT FREE MASS; FAT MASS; FEMALE; FLUORESCENCE; GENE EXPRESSION; HEART RATE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; METABOLIC SYNDROME X; MUSCLE BIOPSY; PHENOTYPE; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ANTIGENS, CD; FEMALE; GLUCOSE CLAMP TECHNIQUE; HISTONE DEACETYLASES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLE, SKELETAL; PROTEIN ARRAY ANALYSIS; RECEPTORS, INTERLEUKIN-6; REPRESSOR PROTEINS; TRANSCRIPTOME; UP-REGULATION;

EID: 84884730397     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.072710     Document Type: Article

References (36)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM & Smith SC Jr (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645.
2. Benjamini Y, Drai D, Elmer G, Kafkafi N & Golani I (2001). Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125, 279-284.
3. Chen SJ, Yen CH, Huang YC, Lee BJ, Hsia S & Lin PT (2012). Relationships between inflammation, adiponectin, and oxidative stress in metabolic syndrome. PLoS One 7, e45693.
4. DeFronzo RA, Tobin JD & Andres R (1979). Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab 237, E214-E223.
5. Du Bois D & Du Bois EF (1989). A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5, 303-311; discussion 312-303.
6. Eckel RH, Grundy SM & Zimmet PZ (2005). The metabolic syndrome. Lancet 365, 1415-1428.
7. Elbein SC, Kern PA, Rasouli N, Yao-Borengasser A, Sharma NK & Das SK (2011). Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI. Diabetes 60, 1019-1029.
8. Ghanim H, Aljada A, Daoud N, Deopurkar R, Chaudhuri A & Dandona P (2007). Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia 50, 278-285.
9. Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, Yarme A, Stetler-Stevenson MA, Siebenlist U & Kelly K (1996). CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 157, 5438-5447.
10. Haberland M, Montgomery RL & Olson EN (2009). The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10, 32-42.
11. Hittel DS, Kraus WE & Hoffman EP (2003). Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome. J Physiol 548, 401-410.
12. Hotamisligil GS (2006). Inflammation and metabolic disorders. Nature 444, 860-867.
13. Huang da W, Sherman BT & Lempicki RA (2009a). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37, 1-13.
14. Huang da W, Sherman BT & Lempicki RA (2009b). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57.
15. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U & Speed TP (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264.
16. Kalupahana NS, Moustaid-Moussa N & Claycombe KJ (2012). Immunity as a link between obesity and insulin resistance. Mol Aspects Med 33, 26-34.
17. Keller C, Steensberg A, Hansen AK, Fischer CP, Plomgaard P & Pedersen BK (2005a). Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol 99, 2075-2079.
18. Keller P, Penkowa M, Keller C, Steensberg A, Fischer CP, Giralt M, Hidalgo J & Pedersen BK (2005b). Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 19, 1181-1183.
19. Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB & Kim JK (2004). Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53, 1060-1067.
20. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, Hauner H, Blüher M, Unger T, Wolf AM, Knippschild U, Hombach V & Marx N (2008). T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28, 1304-1310.
21. Mahoney DJ, Parise G, Melov S, Safdar A & Tarnopolsky MA (2005). Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 19, 1498-1500.
22. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D & Groop LC (2003). PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267-273.
23. Oberbach A, Bossenz Y, Lehmann S, Niebauer J, Adams V, Paschke R, Schön MR, Blüher M & Punkt K (2006). Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care 29, 895-900.
24. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR & Mandarino LJ (2003). Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100, 8466-8471.
25. Pickup JC, Mattock MB, Chusney GD & Burt D (1997). NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40, 1286-1292.
26. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J, Richardson JA, Bassel-Duby R & Olson EN (2007). Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117, 2459-2467.
27. Rome S, Clement K, Rabasa-Lhoret R, Loizon E, Poitou C, Barsh GS, Riou JP, Laville M & Vidal H (2003). Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. J Biol Chem 278, 18063-18068.
28. Salminen M, Kuoppamäki M, Vahlberg T, Räihä I, Irjala K & Kivelä SL (2011). Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland. Acta Diabetol 48, 157-165.
29. Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E & Laakso M (2008). Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study. Diabet Med 25, 747-750.
30. Sattar N, Williams K, Sniderman AD, D'Agostino R Jr & Haffner SM (2004). Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 110, 2687-2693.
31. Scheele C, Nielsen S, Kelly M, Broholm C, Nielsen AR, Taudorf S, Pedersen M, Fischer CP & Pedersen BK (2012). Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS One 7, e39657.
32. Shoelson SE, Lee J & Goldfine AB (2006). Inflammation and insulin resistance. J Clin Invest 116, 1793-1801.
33. Stienstra R, Tack CJ, Kanneganti TD, Joosten LA & Netea MG (2012). The inflammasome puts obesity in the danger zone. Cell Metab 15, 10-18.
34. Verdin E, Dequiedt F & Kasler HG (2003). Class II histone deacetylases: versatile regulators. Trends Genet 19, 286-293.
35. Wilson PW, D'Agostino RB, Parise H, Sullivan L & Meigs JB (2005). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112, 3066-3072.
36. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, DiMarchi RD, Furman TC, Hale JE, Hsiung HM, Schoner BE, Smith DP, Zhang XY, Wery JP & Schevitz RW (1997). Crystal structure of the obese protein leptin-E100. Nature 387, 206-209.